TABLE 2.
Factors | HR | 95% CI | p-value |
Age | 1.024 | 1.001–1.048 | 0.038* |
Gender | 1.064 | 0.697–1.623 | 0.774 |
KPS | 0.987 | 0.976–0.998 | 0.021* |
Treatment | 0.708 | 0.442–1.134 | 0.151 |
Location | 0.749 | 0.326–1.191 | 0.277 |
Number | 1.18 | 0.778–1.788 | 0.436 |
Tumor crossing the midline | 2.417 | 1.42–4.11 | 0.001* |
Maximum tumor diameter | 1.017 | 1.005–1.029 | 0.007* |
Maximum edema diameter | 0.996 | 0.979–1.013 | 0.626 |
PTE | 0.896 | 0.604–1.327 | 0.583 |
Edema shape | 1.069 | 0.753–1.518 | 0.708 |
Edema/tumor diameter | 0.706 | 0.397–1.255 | 0.236 |
Necrosis | 0.961 | 0.613–1.740 | 0.897 |
Cyst | 1.108 | 0.717–1.484 | 0.815 |
Enhancement | 0.942 | 0.663–1.337 | 0.737 |
PTE, peritumoral edema. *p < 0.05.